Aprim Pharmceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 30 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -0.65%
- Profit Growth 372.02%
- Ebitda 65.07%
- Net Worth 2.63%
- Total Assets -1.80%
About Aprim Pharmceuticals
Aprim Pharmceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 June 1994 and has a history of 30 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Sharma and Jag Sharma serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1994PTC059589
-
Company No.
059589
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Jun 1994
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Aprim Pharmceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Sharma
|
Director | 13-Jun-1994 | Current |
|
Jag Sharma
|
Director | 13-Jun-1994 | Current |
Financial Performance of Aprim Pharmceuticals.
Aprim Pharmceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 0.65% decrease. The company also saw a substantial improvement in profitability, with a 372.02% increase in profit. The company's net worth moved up by a moderate rise of 2.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aprim Pharmceuticals?
In 2017, Aprim Pharmceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aprim Pharmceuticals?
Unlock and access historical data on people associated with Aprim Pharmceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aprim Pharmceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aprim Pharmceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.